Comparing Tofacitinib vs Upadacitinib
Tofacitinib | Upadacitinib |
|
---|
Tofacitinib | Upadacitinib |
|
---|---|---|
Prescription only
Prescribed for Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis, Ulcerative Colitis, Polyarticular Juvenile Idiopathic Arthritis. Tofacitinib may also be used for purposes not listed... View more |
Prescription only
Prescribed for Crohn's Disease, Ankylosing Spondylitis, Atopic Dermatitis, Non-Radiographic Axial Spondyloarthritis, Polyarticular Juvenile Idiopathic Arthritis, Giant Cell Arteritis, Psoriatic... View more |
Related suggestions Rheumatoid Arthritis
Ulcerative Colitis
Ankylosing Spondylitis
|
More about Tofacitinib | More about Upadacitinib | |
Ratings & Reviews | ||
Tofacitinib has an average rating of 5.7 out of 10 from a total of 172 ratings on Drugs.com. 44% of reviewers reported a positive effect, while 40% reported a negative effect. |
Upadacitinib has an average rating of 7.0 out of 10 from a total of 232 ratings on Drugs.com. 56% of reviewers reported a positive effect, while 18% reported a negative effect. |
|
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||
View all Tofacitinib side effects |
View all Upadacitinib side effects |
|
Drug Class | ||
Generic Availability | ||
N/A |
N/A |
|
Pricing and Coupons * Prices are without insurance | ||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
Dosage Forms | ||
N/A |
N/A |
|
Brand Names | ||
Xeljanz, Xeljanz Oral Solution, Xeljanz XR | Rinvoq, Rinvoq LQ | |
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||
3 hours |
14 hours |
|
CSA Schedule 1 View glossary of CSA terms | ||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
|
Pregnancy Category | ||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
|
Drug Interactions | ||
A total of 659 drugs are known to interact with Tofacitinib:
|
A total of 599 drugs are known to interact with Upadacitinib:
|
|
Alcohol/Food/Lifestyle Interactions | ||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
|
Disease Interactions | ||
First Approval Date | ||
November 06, 2012 |
August 16, 2019 |
|
WADA Class View classifications | ||
N/A |
N/A |
|
More Information | ||
Patient Resources | ||
Professional Resources | ||
Related Treatment Guide | ||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.